≥99% Purity Verified by Third-Party Labs
    Free Shipping on Orders Over $100
    HPLC & Mass Spec 2X Tested
    Same Day Shipping on Orders Before 2PM EST Mon-Sat
    ≥99% Purity Verified by Third-Party Labs
    Free Shipping on Orders Over $100
    HPLC & Mass Spec 2X Tested
    Same Day Shipping on Orders Before 2PM EST Mon-Sat

    Research use only · Not for human or veterinary use

    Research Compounds
    11/17/2026

    How to Read a Peptide Certificate of Analysis

    A section-by-section walkthrough of a research peptide certificate of analysis — header, identity block, lot data, methods, results table and signatures — and what each part does and does not prove about the material in the vial.

    Reviewed by Alpha Carbon Labs Research TeamLast updated November 17, 2026

    A peptide certificate of analysis (COA) should identify the exact material and lot tested, name the analytical method behind each result, state a specification or acceptance limit beside each measured value, and carry a dated approval from an accountable person. Read it from top to bottom: header, product identity, lot data, test methods, results table, and signatures. Each section supports a narrow claim about the tested sample. None of them, alone or together, proves anything about biological activity or suitability for use in living systems.

    This guide covers the whole document. Other articles go deeper into specific parts. For chromatogram integration, see our guide on how to read a peptide HPLC test report. For the question of who submitted the sample, see what third-party testing does and does not prove.

    What should a peptide Certificate of Analysis actually show?

    A complete peptide COA should contain six things:

    • An issuer header
    • A product identity block with sequence, formula and molecular weight
    • A lot or batch number with relevant dates
    • A list of test methods
    • A results table pairing each measured value with its specification
    • A signed, dated release statement

    If any section is missing, the document is incomplete, not merely brief.

    Regulatory guidance for peptide and protein specifications, such as ICH Q6B, frames the same idea. A specification is a list of tests, analytical procedures and acceptance criteria. Research-grade materials are not held to pharmaceutical release standards, but the logic still applies. A number on a COA only means something when you know how it was measured and what limit it was compared against.

    Key takeaways

    • A COA describes one tested sample from one lot on one date.
    • Identity (is it the right molecule?) and purity (how much of the detected signal is that molecule?) are separate claims, backed by separate tests.
    • Area-percent purity is not the same as peptide content by weight.
    • A result with no method and no specification cannot be interpreted.
    • Signatures establish accountability, not independence or correctness.

    What does the COA header tell you?

    The header identifies who issued the document and who did the testing. These may be different organizations. Look for the issuing company name, a document or report number, a page count (for example, "page 1 of 3"), and, if an outside lab did the analysis, that lab's name and address.

    A unique report number lets the issuer confirm the document on request. A page count shows whether pages are missing. If an accreditation is claimed, check that the accredited scope actually covers the methods listed; our ISO 17025 checklist explains how. A logo on its own does not verify anything.

    What belongs in the product identity block?

    The identity block states what the material is supposed to be. A useful one includes the following:

    • The compound name
    • The full amino acid sequence, including any non-standard residues or modifications
    • Terminal chemistry (C-terminal amide or free acid)
    • The molecular formula
    • The theoretical average and/or monoisotopic mass
    • The salt form or counter-ion, if specified

    This block is a claim, not a result. Its job is to give the analytical data something to be checked against. If the theoretical mass listed doesn't match the stated sequence and modifications, the mass spectrometry comparison later in the document is undermined.

    Details such as amidation change the expected mass by about 1 Da, so they need to be explicit. Our article on amidated peptides vs free acids explains why. Peptides made by solid-phase synthesis, a method first described by Merrifield in 1963, can also carry sequence-related impurities. These include deletions, truncations and incompletely removed protecting groups, and the identity block defines the target they are measured against. Background on how these materials are produced is on our peptide synthesis page.

    How do lot number and dates connect the COA to a vial?

    The lot or batch number links the paper to the physical material. It should match the vial or container label exactly, character for character. Alongside it, look for the following dates:

    • Manufacture date
    • Test date
    • Report issue date
    • A retest or expiry date, if one is assigned

    The order of the dates matters. Testing should happen after manufacture, and the report should be issued after testing. A test date years before the order is not automatically a problem, since lyophilized material can be stable. It does mean the COA reflects the material's condition at that time, not its condition on arrival.

    Some COAs also give a sample quantity or sample ID, which tells you how much material was actually analyzed. If the lot number is missing from the vial itself, follow the steps in what to check when a vial has no lot number rather than assuming the document applies.

    Which test methods should a peptide COA list?

    A peptide COA should name a method for every reported result. Common ones are reversed-phase HPLC for purity, mass spectrometry for identity, and Karl Fischer titration for water. Some COAs also include amino acid analysis or nitrogen determination for peptide content, ion chromatography or HPLC for counter-ion, and, where claimed, endotoxin or sterility testing.

    Method details are what make results reproducible. For HPLC, a well-written COA or its attached report states the following:

    • Column type
    • Mobile phases and gradient
    • Detection wavelength (typically around 214–220 nm for the peptide bond)
    • Run time

    A method listed only as "HPLC" cannot be reproduced or judged. Guidance such as ICH Q2 and USP chapter 1225 describes validation characteristics like specificity, linearity and precision. Research suppliers rarely give full validation data, but it is reasonable to ask whether a method is validated or in-house.

    TestTypical methodWhat it supportsWhat it does not establish
    AppearanceVisual inspectionPhysical form and color at test timeIdentity, purity or content
    IdentityESI or MALDI mass spectrometryObserved mass consistent with theoretical massSequence order; isomers of equal mass; quantity
    PurityRP-HPLC with UV detectionProportion of UV-detected signal in the main peakWeight-percent peptide; impurities that co-elute with the main peak or are not detected
    Peptide contentAmino acid analysis or nitrogen analysisMass fraction of peptide in the powderChemical purity of that peptide
    WaterKarl Fischer titrationWater mass fraction at test timeWater content after storage or after the container is opened
    Counter-ionIon chromatography or HPLCAcetate, TFA or chloride fractionEffects in a specific assay
    EndotoxinLAL assay (USP chapter 85)Endotoxin level in the tested sampleSterility

    How do you read the results table?

    The results table is the core of the COA. Each row should have a test name, a specification (an acceptance limit, such as "≥98.0%" or "conforms to theoretical mass ±1 Da"), the actual result, and a pass/fail or conforms column. Reading it well means checking that all four columns agree with each other.

    Work through each row with these questions:

    1. Is the result a number, or just a word? "Conforms" with no observed mass gives you nothing to check. A good identity row reports the observed mass, for example "observed [M+H]+ 1420.6".
    2. Does the specification match the method's precision? Reporting "99.87%" purity against a "≥98%" limit implies a precision the method may not have. Our article on pass limits and measurement uncertainty covers results close to the limit.
    3. Do the units add up? Peptide content, water and counter-ion are all expressed as weight percent. Together they should approach, but not exceed, roughly 100% of the powder.
    4. Is anything missing? A table with only purity and identity says nothing about how much of the powder is peptide.

    The point in item 3 is often overlooked. Lyophilized peptides routinely hold several percent water and a substantial counter-ion fraction. A sample can therefore show high HPLC purity while its peptide content by weight is well below 100%. Our pieces on moisture in dry powder and counter-ion selection explain why. Counter-ions can also matter for experiments: Cornish and colleagues reported that trifluoroacetate inhibited osteoblast and chondrocyte proliferation in cell culture.

    How should the mass spectrometry result be checked?

    Compare the observed mass with the theoretical mass from the identity block, using the same convention. Average mass and monoisotopic mass differ, and electrospray spectra often show multiply charged ions such as [M+2H]2+ and [M+3H]3+ rather than the intact mass. A COA should state which ion it reports.

    A matching mass is strong evidence that the main component has the expected composition. It is not proof of sequence. Peptides with the same residues in a different order, and epimers containing D-amino acids, can have identical masses (see D vs L amino acids). Confirming sequence requires tandem MS fragmentation or other orthogonal methods, which few research COAs include.

    What do the signatures and approval section prove?

    The approval section usually shows the name, role and signature of the analyst and of a reviewer or QA approver, with dates. Having two different people sign establishes internal review. It also tells you who to contact with questions about the data.

    Signatures do not prove the data are correct, that the testing was independent, or that the document hasn't been altered. Watch for these warning signs:

    • An identical signature image across many unrelated lots
    • Approval dated before the test date
    • No named individual at all

    Contacting the issuing laboratory directly with the report number is the most practical way to confirm a document is authentic. Published surveys of seized and illicitly sold peptide products, such as the work of Vanhee and colleagues, found frequent mismatches between labeled and actual content. This is why document checks should be backed by verification.

    What does a COA not prove about the vial in your hands?

    A COA proves that a sample with a stated lot number gave specific results under specific methods on a specific date. It does not prove that:

    • Your vial came from that lot
    • The fill mass is accurate
    • The material survived shipping and storage unchanged
    • Every vial in the lot is uniform
    • The peptide has any biological activity

    Endotoxin results do not establish sterility, and purity results do not establish either one. Our article on sterility vs purity covers this in detail. Fill accuracy normally needs a separate content-per-vial assay. Degradation after arrival needs retesting; see how to assess peptide degradation in the lab.

    Which red flags suggest a COA needs follow-up?

    Follow up before using material in experiments if you see any of the following:

    • The lot number doesn't match the vial.
    • Results are given without methods or specifications.
    • The theoretical mass is inconsistent with the stated sequence.
    • The purity figure is reused across different compounds or lots.
    • The chromatogram or spectrum is missing or unreadable.
    • Dates are out of order.
    • There is no named approver.
    • The issuer cannot confirm the report number.

    None of these proves a problem on its own. Each one weakens the link between the document and the material. At Alpha Carbon Labs, lot-specific documents are published on our COA documents page, and our testing approach is described on the quality control page. The same reading method applies whether you are looking at a COA for BPC-157 or any other research peptide.

    Frequently Asked Questions

    What is the most important line on a peptide COA?

    No single line is enough. The lot number matters most for traceability, because without a match to the vial, every other result may describe different material. After that, identity by mass spectrometry and purity by HPLC are the core analytical claims. Peptide content and water results determine how much of the powder is actually peptide.

    Does 99% purity mean the vial contains 99% peptide?

    No. HPLC purity is the share of UV-detected signal that falls in the main peak. It is not a weight fraction. Lyophilized peptide powder also contains water and counter-ions such as acetate or trifluoroacetate. A sample can show 99% HPLC purity while peptide content by weight is substantially lower. Content is measured separately, by amino acid or nitrogen analysis.

    Why does the observed mass differ from the listed molecular weight?

    The difference usually comes from conventions. Spectra may report protonated ions ([M+H]+) or multiply charged ions rather than the neutral mass. Average and monoisotopic masses also differ. Compare like with like, using the ion type and mass convention the COA states. A small difference within the stated tolerance is expected. A larger, unexplained difference should be raised with the issuer.

    Is a COA without a chromatogram acceptable?

    A results table without the underlying chromatogram or spectrum is harder to evaluate. It gives no way to check peak integration, baseline handling or the presence of unresolved peaks. Many suppliers provide raw data on request. If the data are not available, treat the reported purity as an unverified summary figure rather than a reviewable measurement.

    Can one COA cover multiple lots?

    It should not. A COA reports results for a sample taken from one specific lot. Different synthesis or purification runs can give different impurity profiles, water content and counter-ion levels. A document listing several lot numbers, or none at all, cannot establish that any particular lot meets specification.

    Does a signed COA mean the testing was independent?

    No. Signatures show that named people performed and reviewed the work and accept responsibility for it. They do not show who selected the sample or whether the testing lab was independent of the supplier. Independence depends on sample chain of custody and on the relationship between the lab and the supplier.

    How old can a COA be and still be useful?

    There is no universal cutoff. A COA reflects the material's condition at the test date. For stable lyophilized material stored properly, older data may still be informative. If there is a retest date, if storage history is unknown, or if degradation is plausible, fresh analysis is the only way to describe the current material.

    Limitations

    This article summarizes general analytical principles and published research on peptide characterization and specifications. It does not establish the safety, effectiveness, regulatory approval or suitability of any material sold by Alpha Carbon Labs for human or veterinary use. All materials are supplied solely for nonclinical laboratory research.

    References

    1. 1. ICH Q6B: Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products. International Council for Harmonisation, 1999.
    2. 2. ICH Q2(R1): Validation of Analytical Procedures: Text and Methodology. International Council for Harmonisation, 2005.
    3. 3. United States Pharmacopeia General Chapter <1225> Validation of Compendial Procedures.
    4. 4. United States Pharmacopeia General Chapter <85> Bacterial Endotoxins Test.
    5. 5. ISO/IEC 17025:2017 General requirements for the competence of testing and calibration laboratories.
    6. 6. Merrifield RB. Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide. Journal of the American Chemical Society. 1963;85(14):2149-2154.
    7. 7. D'Hondt M, Bracke N, Taevernier L, et al. Related impurities in peptide medicines. Journal of Pharmaceutical and Biomedical Analysis. 2014;101:2-30.
    8. 8. Cornish J, Callon KE, Lin CQ, et al. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. American Journal of Physiology. 1999;277(5):E779-E783.
    9. 9. Vanhee C, Janvier S, Desmedt B, et al. Analysis of illegal peptide biopharmaceuticals frequently encountered by controlling agencies. Talanta. 2015;142:1-10.
    10. 10. Fields GB, Noble RL. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. International Journal of Peptide and Protein Research. 1990;35(3):161-214.
    11. 11. Mant CT, Chen Y, Yan Z, et al. HPLC analysis and purification of peptides. Methods in Molecular Biology. 2007;386:3-55.

    All research information is for educational purposes only. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.